Sattar Yasar, Bareeqa Syeda Beenish, Rauf Hiba, Ullah Waqas, Alraies M Chadi
Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
Internal Medicine, Jinnah Medical and Dental College, Karachi, PAK.
Cureus. 2020 Feb 13;12(2):e6985. doi: 10.7759/cureus.6985.
The combination of bradycardia, renal failure, atrioventricular (AV)-nodal blocker medications, shock, and hyperkalemia (BRASH) is a new syndrome that is a consequence of a positive loop of bradycardia due to AV-nodal blockers and hyperkalemia secondary to renal insufficiency. We present a case of BRASH syndrome in which the patient on chronic AV-nodal blockers presented with bradycardia, hypotension, underlying kidney dysfunction, and hyperkalemia. The patient was medically managed and discharged upon clinical improvement. The purpose of this report is to highlight the rare cases of BRASH syndrome and improve its management.
心动过缓、肾衰竭、房室结阻滞剂药物、休克和高钾血症（BRASH）综合征是一种新的综合征，它是由房室结阻滞剂导致的心动过缓正反馈回路以及肾功能不全继发的高钾血症引起的。我们报告一例BRASH综合征病例，该患者长期服用房室结阻滞剂，出现心动过缓、低血压、潜在的肾功能不全和高钾血症。患者经药物治疗后临床症状改善并出院。本报告的目的是强调BRASH综合征的罕见病例并改善其治疗。
